Oral cancer has been reported to be one of the major
cancer-related diseases in human populations and the treatment of
oral cancer is still unsatisfied.
Fisetin, is a
flavonoid from plants and has several biological activities such as
antioxidant, anti-inflammatory and anticancer function, but its cytotoxicity in human
oral cancer cells is unknown. In the present study, we investigated
fisetin-induced cytotoxic effects on HSC3 human
oral cancer cells in vitro. Materials and Methods/Results: We used flow cytometric assay to show
fisetin induced apoptotic cell death through increased
reactive oxygen species and Ca2+, but reduced the mitochondrial membrane potential and increased
caspase-8, -9 and -3 activities in HSC3 cells. Furthermore, we also used 4' 6-diamidino-2-phenylindole staining to show that
fisetin induced
chromatin condensation (apoptotic cell death), and Comet assay to show that
fisetin induced DNA damage in HSC3 cells. Western blotting was used to examine the levels of apoptotic-associated
protein and results indicated that
fisetin increased expression of
pro-apoptotic proteins such as
B-cell lymphoma 2 (BCL2) antagonist/killer (BAK) and BCL2-associated X (BAX) but reduced that of
anti-apoptotic protein such as BCL2 and BCL-x, and increased the cleaved forms of
caspase-3, -8 and -9, and
cytochrome c,
apoptosis-inducing factor (AIF) and
endonuclease G (ENDO G) in HSC3 cells. Confocal microscopy showed that
fisetin increased the release of
cytochrome c, AIF and ENDO G from mitochondria into the cytoplasm.
CONCLUSION: Based on these observations, we suggest that
fisetin induces apoptotic cell death through endoplasmic reticulum stress- and mitochondria-dependent pathways.